Pulmonary tuberculosis with acute respiratory failure

European Respiratory Journal

Volumn 32, Issue 6, 2008, Pages 1625-1630

  Kim, Y J ^a   Pack, K M ^a   Jeong, E ^a   Na, J O ^b   Oh, Y M ^a   Lee, S D ^a   Kim, W S ^a   Kim, D S ^a   Kim, W D ^a   Shim, T S ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Soonchunhyang University College of Medicine   (South Korea)

Author keywords

Corticosteroids; Mortality; Prognostic factors; Respiratory failure; Tuberculosis

Indexed keywords

CORTICOSTEROID; PREDNISOLONE; TUBERCULOSTATIC AGENT;

ACUTE RESPIRATORY FAILURE; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG EFFICACY; FEMALE; GROUPS BY AGE; HOSPITAL ADMISSION; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MILIARY TUBERCULOSIS; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SEPSIS; SHOCK; SURVIVAL; TUBERCULOUS PNEUMONIA;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUBERCULOSIS, MILIARY; TUBERCULOSIS, PULMONARY;

EID: 58849138766     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00070907     Document Type: Article

References (35)

1. Rosen MJ, Clayton K, Schneider RF, et al. Intensive care of patients with HIV infection: utilization, critical illnesses, and outcomes. Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med 1997; 155: 67-71.
2. Pablos-Mendez A, Raviglione MC, Laszlo A, et al. Global surveillance for antituberculosis-drug resistance, 1994-1997. N Engl J Med 1998; 338: 1641-1649.
3. Keim LW, Schuldt S, Bedell GN. Tuberculosis in the intensive care unit. Heart Lung 1977; 6: 624-634.
4. Frame RN, Johnson MC, Eichenhorn MS, et al. Active tuberculosis in the medical intensive care unit: a 15-year retrospective analysis. Crit Care Med 1987; 15: 1012-1014.
5. Penner C, Roberts D, Kunimoto D, et al. Tuberculosis as a primary cause of respiratory failure requiring mechanical ventilation. Am J Respir Crit Care Med 1995; 151: 867-872.
6. Lee PL, Jerng JS, Chang YL, et al. Patient mortality of active pulmonary tuberculosis requiring mechanical ventilation. Eur Respir J 2003; 22: 141-147.
7. Keh D, Boehnke T, Weber-Cartens S, et al. Immunologic and hemodynamic effects of low-dose hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 2003; 167: 512-520.
8. Annane D, Sebille V, Bellissant E. Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med 2006; 34: 22-30.
9. Moton C, Ewig S, Torres A, et al. Role of glucocorticoids on inflammatory response in nonimmunosuppressed patients with pneumonia: a pilot study. Eur Respir J 1999; 14: 218-220.
10. Confalonieri M, Urbino R, Potena A, et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 2005; 171: 242-248.
11. Bernard GR, Luce JM, Sprung CL, et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 1987; 317: 1565-1570.
12. Meduri GU, Golden E, Freire AX, et al. Methylprednisolone infusion in early severe ARDS: result of a randomized controlled trial. Chest 2007; 131: 954-963.
13. Meduri GU, Headley A, Golden E, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled tiral. JAMA 1998; 280: 159-165.
14. Steinbreg KP, Hudson LD, Goodman RB, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006; 354: 1671-1684.
15. Thwaites GE, Bang ND, Dung NH, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004; 351: 1741-1751.
16. Strang JIG, Gibson DG, Nunn AJ, et al. Controlled trial of prednisolone as adjuvant in treatment of tuberculous constrictive pericarditis in Transkei. Lancet 1987; 330: 1418-1422.
17. Bilaceroglu S, Perim J, Buyuksirin M, et al. Prednisolone: a beneficial and safe adjunt to anti-tuberculous treatment: a randomized controlled trial. Int J Tuberc Lung Dis 1999; 3: 47-54.
18. Smego RA, Ahmed N. A systematic review of the adjunctive use of systemic corticosteroids for pulmonary tuberculosis. Int J Tuberc Lung Dis 2003; 7: 208-213.
19. Septimus EJ, Awe RJ, Greenberg SD, Raleigh JW. Acute tuberculous pneumonia. Chest 1977; 71: 774-775.
20. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-824.
21. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International sepsis definition conference. Crit Care Med 2003; 31: 1250-1256.
22. Knaus WA, Draper EA, Wagner DP, et al. Prognosis in acute organ-system failure. Ann Surg 1985; 202: 685-696.
23. Korean Center for Disease Control and Prevention, Korean Institute of Tuberculosis, Korean Tuberculosis Surveillance Center. Annual Report on the Notified Tuberculosis Patients in Korea, 2005. Seoul, Korean Center for Disease Control and Prevention, Korean Institute of Tuberculosis, Korean Tuberculosis Surveillance Center, 2006.
24. Korean Ministry of Health and Welfare. The Prevalence of Human Immunodeficiency Virus (HIV) Infection in Korea. Seoul, Korean Ministry of Health and Welfare, 2004.
25. Heffner JE, Strange C, Sahn SA. The impact of respiratory failure on the diagnosis of tuberculosis. Arch Intern Med 1988; 148: 1103-1108.
26. Homan W, Harman E, Braun NM, et al. Miliary tuberculosis presenting as acute respiratory failure: treatment by membrane oxygenator and ventricle pump. Chest 1975; 67: 366-369.
27. Dyer RA, Chappell WA, Potgieter PD. Adult respiratory distress syndrome associated with miliary tuberculosis. Crit Care Med 1985; 13: 12-15.
28. Lintin SN, Isaac PA. Miliary tuberculosis presenting as adult respiratory distress syndrome. Intensive Care Med 1988; 14: 672-674.
29. Levy H, Kallenbach JM, Feldman C, et al. Acute respiratory failure in active tuberculosis. Crit Care Med 1987; 15: 221-225.
30. Erbes R, Oettel K, Raffenberg M, et al. Characteristics and outcome of patients with active pulmonary tuberculosis requiring intensive care. Eur Respir J 2006; 27: 1223-1228.
31. Zahar JR, Azoulay E, Klement E, et al. Delayed treatment contributes to mortality in ICU patients with severe active pulmonary tuberculosis and acute respiratory failure. Intensive Care Med 2001; 27: 513-520.
32. Muthuswamy P, Hu TC, Carasso B, et al. Prednisone as adjunctive therapy in the management of pulmonary tuberculosis. Report of 12 cases and review of the literature. Chest 1995; 107: 1621-1630.
33. Wallis RS. Reconsidering adjuvant immunotherapy for tuberculosis. Clin Infect Dis 2005; 41: 201-208.
34. Sun TN, Yang JY, Zheng LY, et al. Chemotherapy and its combination with corticosteroids in acute miliary tuberculosis in adolescents and adults: analysis of 55 cases. Chin Med J 1981; 94: 309-314.
35. Massaro D, Katz S, Sachs M. Choroidal tubercles. A clue to hematogenous tuberculosis. Ann Intern Med 1964; 60: 231-241.